USPTO lays ground for review of Fintiv rules

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

USPTO lays ground for review of Fintiv rules

Kathi Vidal
Kathi Vidal

The USPTO's plans to file an Advanced Notice of Proposed Rulemaking related to Fintiv are pending regulatory review

The USPTO has indicated that it plans to initiate regulatory action related to Fintiv, it has emerged.

In a filing with the Office of Information and Regulatory Affairs (OIRA) on Thursday, March 9, the USPTO said it would publish an Advanced Notice of Proposed Rulemaking (ANPRM).

An ANPRM is a preliminary notice that an agency is considering regulatory action. The exact nature of the planned rule changes are unclear but could include draft language of what potential rulemaking will look like and can ask the public what issues it should address.

The OIRA, which reviews draft rules submitted by federal agencies, has 90 days from the date of filing to review requests, although this period can be extended.

The USPTO said its ANPRM would not be economically significant. The OIRA will have to determine whether that’s the case, which is important because agencies must provide more detail if changes are deemed to be economically significant.

Actions are economically significant if they’re likely to have a yearly effect of at least $100 million on the economy, or if the OIRA believes they will materially adversely affect the economy.

If the OIRA doesn’t spot any issues, the USPTO will likely initiate its ANPRM related to Fintiv – the rule introduced in 2020 that compels Patent Trial and Appeal Board judges to discretionarily deny inter partes reviews on the basis that parallel district court cases will finish first.

The office implemented interim guidance in July 2022 addressing Fintiv.

That guidance severely limited when the board could use Fintiv to deny petitions. But the USPTO stated at the time that it would soon explore potential rulemaking on proposed approaches through an ANPRM – which it’s now doing.

News of the ANPRM comes amid a busy time for Fintiv-related matters.

In a judgment yesterday, March 13, the Court of Appeals for the Federal Circuit ruled that tech companies could challenge instructions related to Fintiv because they were issued without notice-and-comment rulemaking.

Notice-and-comment rulemaking requires agencies to issue a Notice of Proposed Rulemaking, but they can issue ANPRMs first to get more information.

If businesses were to prevail on these challenges, the notice-and-comment rulemaking process would be crucial for Fintiv’s survival.

Managing IP will provide further analysis on the Federal Circuit’s ruling in the coming days.


more from across site and SHARED ros bottom lb

More from across our site

Not all private equity firms are the same, so leaders at four externally backed IP firms came together to discuss the frameworks they followed and how they ensured a cultural fit
Top-tier German and Spanish firms are among the advisers on a Europe-wide copyright and licensing tussle concerning the design of the track circuit in Madrid
Partners Alex Wilson and Andreas Kramer say bigger law firm rivals don’t necessarily gain by having a wider jurisdictional reach
VO, which has offices in the Netherlands, Belgium and Germany, is the second European IP firm to secure external backing this week
The Bardehle Pagenberg attorneys-at-law discuss the firm’s Managing IP EMEA Awards 2026 success, Unified Patent Court litigation strategy, and evolving European patent trends
A patent battle between two legal tech companies and a loss for Elon Musk’s xAI against OpenAI were also among the top talking points
With drug prices a hot topic in the US, courts are seemingly more reluctant to prevent the entry of generics to the market
Academic Eden Sarid joins us during Pride Month to discuss queer expression and IP law, Patagonia v Pattie Gonia, and how queer and AI-generated creations both pose novelty concerns
Patent attorney Michael Henson joins the firm to lead its freshly launched blockchain and digital assets practice
A dispute over mammogram technology, and a development in the case between GSK and Moderna were also among the top talking points in recent weeks
Gift this article